Christopher Stone
2012
In 2012, Christopher Stone earned a total compensation of $1.2M as Vice President, General Counsel and Secretary at PDL BioPharma, a 88% increase compared to previous year.
Compensation breakdown
| Bonus | $258,000 |
|---|---|
| Non-Equity Incentive Plan | $464,475 |
| Salary | $390,000 |
| Stock Awards | $110,600 |
| Other | $10,000 |
| Total | $1,233,075 |
Stone received $464.5K in non-equity incentive plan, accounting for 38% of the total pay in 2012.
Stone also received $258K in bonus, $390K in salary, $110.6K in stock awards and $10K in other compensation.
Rankings
In 2012, Christopher Stone's compensation ranked 5,318th out of 11,487 executives tracked by ExecPay. In other words, Stone earned more than 53.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,318 out of 11,487 | 54th |
Division Manufacturing | 1,867 out of 4,252 | 56th |
Major group Chemicals And Allied Products | 450 out of 1,200 | 63rd |
Industry group Drugs | 297 out of 922 | 68th |
Industry Biological Products, Except Diagnostic Substances | 52 out of 165 | 69th |
Source: SEC filing on April 16, 2015.
Stone's colleagues
We found four more compensation records of executives who worked with Christopher Stone at PDL BioPharma in 2012.